BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30442987)

  • 1. Different structures of berberine and five other protoberberine alkaloids that affect P-glycoprotein-mediated efflux capacity.
    Zhang YT; Yu YQ; Yan XX; Wang WJ; Tian XT; Wang L; Zhu WL; Gong LK; Pan GY
    Acta Pharmacol Sin; 2019 Jan; 40(1):133-142. PubMed ID: 30442987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux.
    Shan YQ; Ren G; Wang YX; Pang J; Zhao ZY; Yao J; You XF; Si SY; Song DQ; Kong WJ; Jiang JD
    Metabolism; 2013 Mar; 62(3):446-56. PubMed ID: 23079743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies.
    Mora Lagares L; Minovski N; Caballero Alfonso AY; Benfenati E; Wellens S; Culot M; Gosselet F; Novič M
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the chemosensitizer verapamil on P-glycoprotein substrate efflux in rainbow trout hepatocytes.
    Johnston CU; Kennedy CJ
    Comp Biochem Physiol C Toxicol Pharmacol; 2024 Jan; 275():109763. PubMed ID: 37820937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Oxidation on Berberine-Mediated CYP1 Inhibition: Oxidation Behavior and Metabolite-Mediated Inhibition.
    Lo SN; Shen CC; Chang CY; Tsai KC; Huang CC; Wu TS; Ueng YF
    Drug Metab Dispos; 2015 Jul; 43(7):1100-7. PubMed ID: 25953522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein.
    Chufan EE; Kapoor K; Ambudkar SV
    Biochem Pharmacol; 2016 Feb; 101():40-53. PubMed ID: 26686578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
    Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
    J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory Effect of Berberine on Broiler P-glycoprotein Expression and Function: In Situ and In Vitro Studies.
    Zhang Y; Guo L; Huang J; Sun Y; He F; Zloh M; Wang L
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efflux mechanism and pathway of verapamil pumping by human P-glycoprotein.
    Wang L; Sun Y
    Arch Biochem Biophys; 2020 Dec; 696():108675. PubMed ID: 33197430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Identification of Berberine Metabolites in Rat Plasma by UHPLC-Q-TOF-MS.
    Xu P; Xu C; Li X; Li D; Li Y; Jiang J; Yang P; Duan G
    Molecules; 2019 May; 24(10):. PubMed ID: 31137649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrometric studies of cytotoxic protoberberine alkaloids binding to double-stranded DNA.
    Chen WH; Qin Y; Cai Z; Chan CL; Luo GA; Jiang ZH
    Bioorg Med Chem; 2005 Mar; 13(5):1859-66. PubMed ID: 15698803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1).
    Nies AT; Herrmann E; Brom M; Keppler D
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Feb; 376(6):449-61. PubMed ID: 18157518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ion-pair formation with bile salts on the in vitro cellular transport of berberine.
    Chae HW; Kim IW; Jin HE; Kim DD; Chung SJ; Shim CK
    Arch Pharm Res; 2008 Jan; 31(1):103-10. PubMed ID: 18277615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrandrine potentiates the hypoglycemic efficacy of berberine by inhibiting P-glycoprotein function.
    Shan YQ; Zhu YP; Pang J; Wang YX; Song DQ; Kong WJ; Jiang JD
    Biol Pharm Bull; 2013; 36(10):1562-9. PubMed ID: 23924821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Function Relationships in the Human P-Glycoprotein (ABCB1): Insights from Molecular Dynamics Simulations.
    Mora Lagares L; Pérez-Castillo Y; Minovski N; Novič M
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolites of protoberberine alkaloids in human urine following oral administration of Coptidis Rhizoma decoction.
    Yang Y; Kang N; Xia H; Li J; Chen L; Qiu F
    Planta Med; 2010 Nov; 76(16):1859-63. PubMed ID: 20549593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of flavonoids on P-glycoprotein in vitro and in vivo: Food/herb-drug interactions and structure-activity relationships.
    Bai J; Zhao S; Fan X; Chen Y; Zou X; Hu M; Wang B; Jin J; Wang X; Hu J; Zhang D; Li Y
    Toxicol Appl Pharmacol; 2019 Apr; 369():49-59. PubMed ID: 30790579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of Berberine Hypoglycemic Activity by Oligomeric Proanthocyanidins.
    Zhang H; Wang X; Wang T; Chen K; Wang H; Jia Q; Li Y
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30558158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers.
    Troutman MD; Thakker DR
    Pharm Res; 2003 Aug; 20(8):1200-9. PubMed ID: 12948018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the Interaction of A
    Abel B; Tosh DK; Durell SR; Murakami M; Vahedi S; Jacobson KA; Ambudkar SV
    Mol Pharmacol; 2019 Aug; 96(2):180-192. PubMed ID: 31127007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.